186 related articles for article (PubMed ID: 17522418)
1. Recombinant adenovirus mediated prostate-specific enzyme pro-drug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter.
Zeng H; Wei Q; Huang R; Chen N; Dong Q; Yang Y; Zhou Q
J Androl; 2007; 28(6):827-35. PubMed ID: 17522418
[TBL] [Abstract][Full Text] [Related]
2. Improved effects of a double suicide gene system on prostate cancer cells by targeted regulation of prostate-specific membrane antigen promoter and enhancer.
Zhang P; Zeng H; Wei Q; Lu Y; Li X; Wang J; Zhao F; Li H
Int J Urol; 2008 May; 15(5):442-8. PubMed ID: 18452463
[TBL] [Abstract][Full Text] [Related]
3. Construction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter/enhancer.
Zeng H; Wu Q; Li H; Wei Q; Lu Y; Li X; Wang F; Zhao F; Ding Z; Yang Y
J Androl; 2005; 26(2):215-21. PubMed ID: 15713827
[TBL] [Abstract][Full Text] [Related]
4. Specific targeting of prostate cancer cells in vitro by the suicide gene/prodrug system, uracil phosphoribosyltransferase/5-fluorouracil, under the control of prostate-specific membrane antigen promoter/enhancer.
Zhao FJ; Zhang S; Yu ZM; Xia SJ; Li H
Prostate Cancer Prostatic Dis; 2009; 12(2):166-71. PubMed ID: 18626508
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.
O'Keefe DS; Uchida A; Bacich DJ; Watt FB; Martorana A; Molloy PL; Heston WD
Prostate; 2000 Oct; 45(2):149-57. PubMed ID: 11027414
[TBL] [Abstract][Full Text] [Related]
6. [Construction and expression of recombinant plasmid with prostate-specific membrane antigen promoter and enhancer regulating uracil phosphoribosyltransferase gene].
Zhao FJ; Li H; Cheng HM; Zeng H; Wei Q; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):172-5. PubMed ID: 15807258
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.
Li X; Zhang YP; Kim HS; Bae KH; Stantz KM; Lee SJ; Jung C; Jiménez JA; Gardner TA; Jeng MH; Kao C
Cancer Res; 2005 Mar; 65(5):1941-51. PubMed ID: 15753394
[TBL] [Abstract][Full Text] [Related]
8. [The construction of recombinant plasmid with prostate-specific membrane antigen promoter controlling reporter gene expression].
Zeng H; Li H; Liao YC; Li X; Wu Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):169-71. PubMed ID: 15807257
[TBL] [Abstract][Full Text] [Related]
9. Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.
Zhao W; Xu Y; Kong D; Liu R; Zhang Z; Jin C; Zhang Z; Xiu Y
Urol Oncol; 2009; 27(5):539-47. PubMed ID: 18639471
[TBL] [Abstract][Full Text] [Related]
10. Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer.
Hattori Y; Maitani Y
Cancer Sci; 2006 Aug; 97(8):787-98. PubMed ID: 16800821
[TBL] [Abstract][Full Text] [Related]
11. Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter.
Gao XF; Zhou T; Chen GH; Xu CL; Ding YL; Sun YH
Asian J Androl; 2014; 16(1):120-3. PubMed ID: 24369144
[TBL] [Abstract][Full Text] [Related]
12. In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy.
Uchida A; O'Keefe DS; Bacich DJ; Molloy PL; Heston WD
Urology; 2001 Aug; 58(2 Suppl 1):132-9. PubMed ID: 11502468
[TBL] [Abstract][Full Text] [Related]
13. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
[TBL] [Abstract][Full Text] [Related]
14. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
Liu R; Sun J; Zhang Z; Xu Y
Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
[TBL] [Abstract][Full Text] [Related]
15. Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model.
Dzojic H; Cheng WS; Essand M
Cancer Gene Ther; 2007 Mar; 14(3):233-40. PubMed ID: 17053814
[TBL] [Abstract][Full Text] [Related]
16. [Constructing recombinant plasmid with prostate-specific membrane antigen promoter and reverse enhancer and comparing the transcription activity of enhancers in different directions].
Zeng H; Liao YC; Wang F; Wu Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):782-5. PubMed ID: 16334552
[TBL] [Abstract][Full Text] [Related]
17. Novel prostate-specific promoter derived from PSA and PSMA enhancers.
Lee SJ; Kim HS; Yu R; Lee K; Gardner TA; Jung C; Jeng MH; Yeung F; Cheng L; Kao C
Mol Ther; 2002 Sep; 6(3):415-21. PubMed ID: 12231179
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
19. Development of gene therapy using prostate-specific membrane antigen promoter/enhancer with Cre Recombinase/LoxP system for prostate cancer cells under androgen ablation condition.
Ikegami S; Tadakuma T; Suzuki S; Yoshimura I; Asano T; Hayakawa M
Jpn J Cancer Res; 2002 Oct; 93(10):1154-63. PubMed ID: 12417046
[TBL] [Abstract][Full Text] [Related]
20. Ad5/35E1aPSESE4: A novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA/PSMA transcription regulatory elements.
Hwang JE; Joung JY; Shin SP; Choi MK; Kim JE; Kim YH; Park WS; Lee SJ; Lee KH
Cancer Lett; 2016 Mar; 372(1):57-64. PubMed ID: 26723876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
